Advanced Enzyme Technologies Temettüler ve Geri Alımlar
Temettü kriter kontrolleri 4/6
Advanced Enzyme Technologies kazançlarla iyi bir şekilde karşılanan, 1.39% cari getiriye sahip, temettü ödeyen bir şirkettir.
Anahtar bilgiler
1.4%
Temettü verimi
-0.009%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 1.4% |
| Gelecekteki Temettü Verimi | 0.5% |
| Temettü Büyümesi | 32.1% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | ₹5.100 |
| Ödeme oranı | 42% |
Son temettü ve geri alım güncellemeleri
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Temettü ödemeleri istikrarlı olsa da ADVENZYMES 10 yıldan az bir süredir temettü ödüyor.
Büyüyen Temettü: ADVENZYMES şirketinin temettü ödemeleri artmış, ancak şirket yalnızca 7 yıldır temettü ödemiştir.
Piyasaya Karşı Temettü Getirisi
| Advanced Enzyme Technologies Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (ADVENZYMES) | 1.4% |
| Pazarın Alt %25'i (IN) | 0.3% |
| Pazarın En İyi %25'i (IN) | 1.2% |
| Sektör Ortalaması (Chemicals) | 0.7% |
| Analist tahmini (ADVENZYMES) (3 yıla kadar) | 0.5% |
Önemli Temettü: ADVENZYMES 'in temettüsü ( 1.39% ), Indian piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 0.25% ) daha yüksektir.
Yüksek Temettü: ADVENZYMES 'in temettüsü ( 1.39% ) Indian pazarındaki temettü ödeyenlerin en üst %25'indedir ( 1.15% )
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Oldukça düşük ödeme oranı ( 41.6% ) ile ADVENZYMES 'un temettü ödemeleri kazançlarla oldukça iyi bir şekilde karşılanıyor.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Makul nakit ödeme oranı ( 63.1% ) ile ADVENZYMES 'un temettü ödemeleri nakit akışları ile karşılanmaktadır.